← Browse by Condition

Medical Condition

mantle cell lymphoma

Total Trials

11

Recruiting Now

11

Trial Phases

Phase 2, Phase 1, Phase 2, Phase 3

NCT04195633 Phase 2

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Fred Hutchinson Cancer Center

NCT05281809 Phase 2

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

NCT05006716 Phase 1, Phase 2

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

United States, Austr...

BeOne Medicines

NCT03523975 Phase 1, Phase 2

Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

City of Hope Medical Center

Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy

Adaptive Biotechnologies

NCT05529069 Phase 2

Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients

M.D. Anderson Cancer Center

NCT01804686 Phase 3

A Long-term Extension Study of PCI-32765 (Ibrutinib)

United States, Argen...

Janssen Research & Development...

NCT06252675 Phase 2

Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

University of California, San ...

NCT04855695 Phase 1, Phase 2

Avo In R/R And Previously Untreated MCL

NCT05432635 Phase 1

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

City of Hope Medical Center

NCT06357676 Phase 1, Phase 2

Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial

OHSU Knight Cancer Institute